Pay in 4 interest-free payments of $47.50 Learn more
Ships within 48 hours · Estimated delivery Oct 13 - Oct 18
in spontaneously hypertensive rats
CAS Number: 7013-05-0
Avasimibe could be an efficient therapy in the treatment of glioblastoma
Honokiol may act as a potent anti-inflammatory agent with multipotential activities due to an inhibitory effect on the PI3K/Akt pathway
administered orally at 3 mg/kg
Cilomilast Size:10mg solid in spontaneously hypertensive ratsCilomilast (Ariflo, SB 207, 499) is a drug which was developed for the treatment of respiratory disorders such as asthma and Chronic Obstructive Pulmonary Disease (COPD). It is orally active and acts as a selective Phosphodiesterase 4 inhibitor. Clinical trial results showed reasonable efficacy for treating COPD, but side effects were problematic and it is unclear whether cilomalast will be marketed, or merely used in the development of newer drugs.